Bluebird Bio

Award Value
Strategic Partnership I: David Davidson A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia by Transplantation of Autologous Hematopoietic Stem Cells [REDACTED] $0
Total:
$0.00
Icon for xls export